Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Ovoca Bio (OVB) Share News

UK shareholder meetings calendar - next 7 days

11th Dec 2024 11:51

EARNINGS: Origin Enterprises profit falls; GENinCode loss narrows

25th Sep 2024 18:02

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Wednesday and Tuesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Directa Plus flags full-year revenue drop

25th Sep 2024 10:43

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Wednesday. Read More

DIRECTOR DEALINGS: Jet2 chair buys; Ovoca Bio's old CEO sells to new

15th Jul 2024 13:15

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News: Read More

EARNINGS: AssetCo proposes name change; i(x) Net Zero eyes AIM exit

3rd Jul 2024 13:48

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued last week and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

23rd Nov 2023 15:53

EARNINGS: Ovoca "to adapt" after study let-down, Kelso NAV rises

28th Sep 2023 14:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

LONDON MARKET CLOSE: FTSE 100 down amid stubborn US inflation

31st Aug 2023 16:50

(Alliance News) - Stock prices in London closed mixed on Thursday, after news that a key US inflation reading came in in line with market expectations. Read More

Ovoca Bio shares dive following disappointing Orenetide study results

31st Aug 2023 12:08

(Alliance News) - Ovoca Bio PLC shares plummeted on Thursday, after it said that a study into Orenetide did not show statistically significant superiority versus placebo. Read More

AIM WINNERS & LOSERS: Ovoca Bio plunges on disappointing study results

31st Aug 2023 10:43

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

LONDON MARKET OPEN: Stocks struggle ahead of key inflation prints

31st Aug 2023 08:58

(Alliance News) - The FTSE 100 opened marginally higher on Thursday morning as market attention shifted nervously to key inflation prints from the US and EU later in the day. Read More

EARNINGS SUMMARY: Powerhouse loss widens hugely, DCI Advisors narrows

30th Jun 2023 17:26

(Alliance News) - The following is a round-up of 2022 annual results by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed

12th Jun 2023 10:13

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Ovoca Bio shares down as study delayed due to staffing issues

12th Jun 2023 09:01

(Alliance News) - Ovoca Bio PLC shares fell on Monday, after it said that its study into a novel treatment for women with hypoactive sexual desire disorder has been delayed. Read More

IN BRIEF: Ovoca Bio jumps on EUR1.1 million sale of Russian assets

8th Mar 2023 14:21

Ovoca Bio PLC - Dublin-based biopharmaceutical company with a focus on women's health - Agrees to dispose of some of its Russian assets to Desirix LLC for EUR1.1 million. Ovoca agrees to sell assets related to its clinical development product Orenetide, namely the Russian patents for Orenetide, the results of completed scientific development of Orenetide in Russia, together with the right to own a Russian marketing authorization for Orenetide in Russia. Read More

FTSE 100 Latest

Value8,809.74

Change53.53